This Article Full Text Full Text (PDF) All Versions of this Article: 110/18/2896    most recent 01.CIR.0000146342.30470.30v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ono, M. Articles by Matsuda, H. Search for Related Content PubMed PubMed Citation Articles by Ono, M. Articles by Matsuda, H. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Medline Plus Health Information Genes and Gene Therapy Pulmonary Hypertension Hazardous Substances DB MONOCROTALINE Related Collections Animal models of human disease Smooth muscle proliferation and differentiation Pulmonary circulation and disease Pediatric and congenital heart disease, including cardiovascular surgery Gene therapy Mechanism of atherosclerosis/growth factors

(Circulation. 2004;110:2896-2902.)
© 2004 American Heart Association, Inc.

Molecular Cardiology

Hepatocyte Growth Factor Suppresses Vascular Medial Hyperplasia and Matrix Accumulation in Advanced Pulmonary Hypertension of Rats

Masamichi Ono, MD, PhD; Yoshiki Sawa, MD, PhD; Shinya Mizuno, PhD; Norihida Fukushima, MD, PhD; Hajime Ichikawa, MD; Kazuhiko Bessho, MD; Toshikazu Nakamura, PhD; Hikaru Matsuda, MD, PhD

From the Division of Cardiovascular Surgery, Department of Surgery (M.O., Y.S., N.F., H.I., H.M.), and the Division of Molecular Regenerative Medicine, Department of Regenerative Medicine, Course of Advanced Medicine (S.M., K.B., T.N.), Osaka University Graduate School of Medicine, Osaka, Japan.

Correspondence to Dr Yoshiki Sawa, Division of Cardiovascular Surgery, Department of Surgery, Osaka University, Graduate School of Medicine, Yamada-Oka 2-2, Suita, 565-0871, Osaka, Japan. E-mail sawa{at}surg1.med.osaka-u.ac.jp

Received February 8, 2004; de novo received May 16, 2004; accepted July 27, 2004.

Background— Pulmonary hypertension (PH) is a progressive disease characterized by raised pulmonary vascular resistance, thought to be curable only through lung transplantation. Pathophysiologically, proliferation of pulmonary artery smooth muscle cells triggers pulmonary arterial stenosis and/or regurgitation, especially in advanced PH.

Methods and Results— Using a rat model of advanced pulmonary vascular disease produced by injecting monocrotaline, we show that hepatocyte growth factor (HGF) targets pulmonary arterioles and blocks the progression of PH. In these rats, endogenous HGF production was dramatically downregulated during developing experimental PH, but c-Met/HGF receptor was abundant in the medial layers of pulmonary arterioles. HGF gene transfection 2 weeks after the monocrotaline injection resulted in milder medial hyperplasia in lung arterioles and inhibited overgrowth of pulmonary artery smooth muscle cells. Notably, exogenous HGF reduced lung expression levels of endothelin-1 and transforming growth factor-ß, which are critically involved in PH-linked fibrogenic events. Overall, medial wall thickening of pulmonary arteries was almost completely prevented by HGF, and the total collagen deposition in the lung decreased; both effects contributed to the suppression of pulmonary artery hypertension.

Conclusions— Our results suggest that the loss of endogenous HGF may be a feature of the pathogenesis of PH and that HGF supplementation may minimize pathological lung conditions, even advanced PH.

Key Words: gene therapy • pulmonary vasculature • growth factor • remodeling

This article has been cited by other articles:

				L. Dewachter, S. Adnot, C. Guignabert, L. Tu, E. Marcos, E. Fadel, M. Humbert, P. Dartevelle, G. Simonneau, R. Naeije, et al. Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension Eur. Respir. J., November 1, 2009; 34(5): 1100 - 1110. [Abstract] [Full Text] [PDF]

				F. Kamezaki, H. Tasaki, K. Yamashita, M. Tsutsui, S. Koide, S. Nakata, A. Tanimoto, M. Okazaki, Y. Sasaguri, T. Adachi, et al. Gene Transfer of Extracellular Superoxide Dismutase Ameliorates Pulmonary Hypertension in Rats Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 219 - 226. [Abstract] [Full Text] [PDF]

				T. Ito, T. Okada, J. Mimuro, H. Miyashita, R. Uchibori, M. Urabe, H. Mizukami, A. Kume, M. Takahashi, U. Ikeda, et al. Adenoassociated Virus Mediated Prostacyclin Synthase Expression Prevents Pulmonary Arterial Hypertension in Rats Hypertension, September 1, 2007; 50(3): 531 - 536. [Abstract] [Full Text] [PDF]

				W. W. Raymond, A. C. Cruz, and G. H. Caughey Mast Cell and Neutrophil Peptidases Attack an Inactivation Segment in Hepatocyte Growth Factor to Generate NK4-like Antagonists J. Biol. Chem., January 20, 2006; 281(3): 1489 - 1494. [Abstract] [Full Text] [PDF]